Prices delayed by at least 15 minutes | Print
Oxford Biomedica PLC (OXB)
ORD 50POpen
295.00p
Previous close
299.50p
Trade high
309.50p
Volume
36,874
Year high
455.00p
Year low
212.50p
Dividend yield
–
Market capitalisation
£321.17 mn
P/E ratio
20.62
ISIN
GB00BDFBVT43
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Regular investment and Dividend reinvestment
Share price
Company profile
Oxford BioMedica PLC is a contract development and manufacturing organization (CDMO) focused on cell and gene therapy. The company specializes in viral vector development and manufacturing for cell and gene therapy, with expertise in lentivirus, adeno-associated virus (AAV), adenovirus and other viral vector types.
News
Recent trades
| Date | Time | Price | Quantity | Value (£) |
|---|---|---|---|---|
| 25/04/2025 | 03:05:05 | 301 | 155 | 466.55 |
| 25/04/2025 | 03:05:05 | 301 | 250 | 752.50 |
| 25/04/2025 | 03:05:05 | 300.5 | 6 | 18.03 |
| 25/04/2025 | 03:05:05 | 300.5 | 60 | 180.30 |
| 25/04/2025 | 03:05:05 | 300.5 | 400 | 1,202.00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.